Results 151 to 160 of about 274,618 (211)

CSF proteomics identifies ADGRG1 as a predictive biomarker of intrathecal immune checkpoint inhibitor response in leptomeningeal metastasis. [PDF]

J Immunother Cancer
Wang L, Yang G, Lei H, Zhang Y, Li B, Liu M, Huang Y, Chen X, Tai P, Pan Z.   +9 more
europepmc   +1 more source

Predictive factors for clinical outcome of palliative ventriculoperitoneal shunt in the treatment of leptomeningeal metastasis. [PDF]

Transl Cancer Res
Min L, Zhang N, Zhang Q, Zheng M, Zhu Y.
europepmc   +1 more source

Leptomeningeal metastasis in triple-negative breast cancer: a retrospective study. [PDF]

Discov Oncol
Wang YY, Ying XH, Zhang KY, Chen L, Xiao Q, Wang ZH.   +5 more
europepmc   +1 more source

"Bloomy Rind on Cheese Sign" - A Radiological Biomarker of Leptomeningeal Metastasis. [PDF]

Ann Indian Acad Neurol
Shaik RS, Yareeda S, Reddy S, Srivastava MK, Uppin MS, Sagi P.   +5 more
europepmc   +1 more source

Different methods of cerebrospinal fluid diversion in patients with leptomeningeal metastasis: A systematic review and meta-analysis. [PDF]

Surg Neurol Int
Pangaribuan V, Parenrengi MA, Suryaningtyas W, Al Fauzi A, Fahmi A, Utomo B, Susilo RI.   +6 more
europepmc   +1 more source

[Deafness from leptomeningeal metastasis].

Neurologia (Barcelona, Spain), 1997
F J, Hernández-Ramos, P J, Serrano-Castro   +1 more
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Leptomeningeal Metastasis

Cancer Investigation, 2005
Leptomeningeal metastasis is a common complication of cancer. Often the diagnosis can be difficult, but early diagnosis and aggressive treatment can prevent irreversible neurologic deficits. Diagnosis is usually established by the demonstration of malignant cells in the cerebrospinal fluid (CSF) or by the presence of enhancing tumor nodules on cranial ...
Lisa M DeAngelis
exaly   +5 more sources